|
ICK expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.64257496493292E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.13490336520294E-11 |
| Normal-vs-Stage2 |
7.01940000014112E-07 |
| Normal-vs-Stage3 |
2.33546515460148E-12 |
| Normal-vs-Stage4 |
4.08162392773193E-12 |
| Stage1-vs-Stage2 |
6.219800E-01 |
| Stage1-vs-Stage3 |
1.555850E-01 |
| Stage1-vs-Stage4 |
2.139700E-02 |
| Stage2-vs-Stage3 |
1.370370E-01 |
| Stage2-vs-Stage4 |
3.111800E-02 |
| Stage3-vs-Stage4 |
4.019000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.41615624677161E-13 |
| Normal-vs-AfricanAmerican |
1.014070E-04 |
| Normal-vs-Asian |
2.44200004662076E-09 |
| Caucasian-vs-AfricanAmerican |
5.118400E-01 |
| Caucasian-vs-Asian |
6.649000E-01 |
| AfricanAmerican-vs-Asian |
3.441400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.7256864260371E-12 |
| Normal-vs-Female |
1.9257928585148E-12 |
| Male-vs-Female |
5.454600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.42750280882365E-11 |
| Normal-vs-Age(41-60Yrs) |
1.07802655691103E-13 |
| Normal-vs-Age(61-80Yrs) |
1.94609994785822E-10 |
| Normal-vs-Age(81-100Yrs) |
1.975080E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.428200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.230400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.671000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.514600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.918200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.735400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.315000E-01 |
| Classical-VS-Follicular |
8.634800E-01 |
| Classical-VS-Other |
3.803600E-01 |
| Classical-VS-Normal |
4.03044264629671E-12 |
| Tall-VS-Follicular |
2.791200E-01 |
| Tall-VS-Other |
7.594400E-01 |
| Tall-VS-Normal |
3.92129995141488E-09 |
| Follicular-VS-Other |
4.832200E-01 |
| Follicular-VS-Normal |
4.53799999799998E-08 |
| Other-VS-Normal |
1.137290E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.81692463694117E-12 |
| Normal-vs-N1 |
6.46169995288659E-09 |
| N0-vs-N1 |
5.845800E-01 |
|
|
